Becker's Oncology

Tempus and New York City-based NYU Langone Health have formed a multi-year strategic collaboration to advance cancer research through molecular profiling and data-driven insights. The partnership will support NYU Langone Health’s Center for Molecular Oncology at the Laura and Isaac…

Tampa (Fla.) General Hospital and Somerville, Mass.-based Mass General Brigham have launched a joint ambulatory care network to serve Florida’s East Coast and expand outpatient services. The joint venture will provide advanced imaging, oncology, outpatient surgery, primary care and specialty…

Tampa, Fla.-based Moffitt Cancer Center has opened an outpatient facility on its Land O’ Lakes, Fla.-based research and medical campus, Speros.  The Moffitt Speros Outpatient Center is also home to the Richard M. Schulze Family Foundation Proton Therapy Center, according…

Atara Biotherapeutics received a second complete response letter from the FDA for its biologics license application for Ebvallo (tabelecleucel). The letter, received Jan. 9, said the FDA no longer considers the single-arm ALLELE trial adequate to support accelerated approval for…

The FDA has updated guidance outlining how it applies regulatory flexibility to chemistry, manufacturing and control requirements for cell and gene therapies. The agency said the approach is meant to expedite development of complex biologics without compromising safety, purity or…

Breakthroughs in cancer research continue to emerge from academic medical centers, with recent studies finding new ways to target tumors, guide treatment decisions and improve immunotherapy effectiveness.  From nanoparticles to genetic discoveries, here are five recent breakthroughs from cancer researchers…

Detroit-based Henry Ford Health has formed a joint venture with BAMF Health to expand access to precision diagnostics and treatment for patients in the region. Under the partnership, the organizations will establish a 45,000-square-foot comprehensive theranostics center in downtown Detroit.…

Chicago-based Northwestern Medicine has built one of the country’s most ambitious transplant programs. Whether performing the first double lung-liver transplant in the U.S., eliminating all traces of colorectal cancer for a terminal patient through a liver transplant, providing an anesthesia-free…

About 7.5 million Medicaid-enrolled adults may lose coverage for cancer screening within the first two years after implementation of the 2025 Budget Reconciliation Bill, according to a study published Jan. 8 in JAMA Oncology.  The 2025 Budget Reconciliation Bill —…

New York City-based Mount Sinai’s Tisch Cancer Center has launched a new AI platform designed to help more cancer patients across its health system find and enroll in clinical trials. The platform, called PRISM, uses an oncology-specific large language model…